Consultation outcome

British Pharmacopoeia Commission: triennial review

From:
Department of Health and Social Care and Medicines and Healthcare products Regulatory Agency
Published
1 December 2014
Last updated
26 March 2015 — See all updates
This was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government
This consultation has concluded

Read the full outcome

Triennial review of the British Pharmacopoeia Commission: review report

PDF, 807 KB, 51 pages

Detail of outcome

The key conclusion of the triennial (3 yearly) review was that the BPC performs necessary functions and should continue to operate as an advisory non-departmental public body. The review report also contains recommendations to improve performance, governance, and efficiency.

Original consultation

Summary

Seeks views on the role and performance of the British Pharmacopoeia Commission (BPC)

This consultation ran from
to

Consultation description

The department reviews all its arm’s length bodies once every 3 years.

This triennial (3 yearly) review looks at what the BPC does and how.

We want to know what you think of the BPC, including:

  • whether the BPC needs to continue in its current form
  • how the BPC is performing
  • whether the BPC is providing good value

Documents

Triennial Review of the British Pharmacopoeia Commission

PDF, 131 KB, 8 pages

Updates to this page

Published 1 December 2014
Last updated 26 March 2015 + show all updates

  1. Consultation response added.

  2. First published.

Sign up for emails or print this page